...
首页> 外文期刊>Materials science & engineering >Cartilage tissue engineering using injectable functionalized Demineralized Bone Matrix scaffold with glucosamine in PVA carrier, cultured in microbioreactor prior to study in rabbit model
【24h】

Cartilage tissue engineering using injectable functionalized Demineralized Bone Matrix scaffold with glucosamine in PVA carrier, cultured in microbioreactor prior to study in rabbit model

机译:软骨组织工程使用注射功能化脱矿质骨基质支架与PVA载体中的氨基葡萄糖,在兔模型进行研究之前在微生物反应器中培养

获取原文
获取原文并翻译 | 示例
           

摘要

Using 3D model of injectable scaffolds for cartilage tissue engineering is one of the challenges that should be addressed to avoid invasive surgery for treatment. For this purpose, chondrocytes on Demineralized Bone Matrix (DBM) scaffolds functionalized with glucosamine in 20% polyvinyl alcohol (PVA) as a carrier was applied to the micro-bioreactor in-vitro, then the study was continued on in-vivo stage. Scaffold biocompatibility tests were performed and the mechanical and physicochemical properties were studied showing the fact that DBM was functionalized by Glucosamine, scaffold degradation rate was 53% after 720 h and swelling ratio was 2.5 times after 16 h, injectable scaffold demonstrated better mechanical characteristics (P 0.05) than other concentrations of PVA. Consequently, in-vitro tests, including live-dead imaging resulting in 99% viability after 14 days (P 0.001), DAPI staining and scanning electron microscope imaging were performed to determine the number and viability of the cells on the scaffold, showing a cells proliferation property of this group compared with the control after 14 days (P 0.0001), then relative gene expression was evaluated and protein expression was assessed. The overall chondrogenic gene expression improved (P 0.05) compared to the control (2D culture). Subsequently, the scaffold were loaded with chondrocytes and injected into the cartilage lesion part After 24 weeks of surgery, MRI and immunocytochemistry were performed. Then all outputs proved that the scaffold plus cell group had a significantly higher topological score (P 0.0001) than other groups compared to normal cartilage. Finally, studies have shown that transplantation of chondrocytes in DBM, polyvinyl alcohol and glucosamine scaffold through one surgical stage improves cartilage lesion and it can be considered as a breakthrough in tissue engineering.
机译:使用用于软骨组织工程的可注射支架的3D模型是应解决的挑战之一,以避免侵入性手术治疗。为此目的,在体外,用葡糖胺在20%聚乙烯醇(PVA)中用氨基甲磺酸(PVA)官能化的软骨骨基质(DBM)支架上官能团中的微生物反应器施用于微生物反应器,然后继续进行该研究。进行支架生物相容性试验,研究了机械和物理化学性质表明DBM通过葡糖胺官能化,在720小时后,支架降解速率为53%,16小时后溶胀比率为2.5次,可注射支架显示出更好的机械特性(P <0.05)比其他浓度的PVA。因此,在体外测试中,包括活死成像,得到14天后的99%活力(P <0.001),进行DAPI染色和扫描电子显微镜成像以确定细胞在支架上的数量和存活率,显示该组细胞增殖性能与14天后对照进行比较(P <0.0001),然后评价相对基因表达,并评估蛋白质表达。与对照(2D培养物)相比,整体软骨基因表达改善(P <0.05)。随后,用软骨细胞加载支架并在手术24周后注射到软骨病变部分中,进行MRI和免疫细胞化学。然后,所有产出证明,与正常软骨相比,脚手架加细胞组比其他组具有明显更高的拓扑分数(P <0.0001)。最后,研究表明,通过一个手术期通过一种手术阶段的DBM,聚乙烯醇和葡糖胺支架的移植改善了软骨病变,它可以被认为是组织工程中的突破。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号